Total current assets Total assets Total current liabilities Total liabilities Class of Stock [Axis] Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Total operating expenses Income (Loss) from operations Income (loss) from operations Other income (expense), net Other income (expense), net Net income (loss) Net income (loss) Net income (loss) attributable to common stockholders Other comprehensive income (loss) Comprehensive income (loss) Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash provided by (used in) operating activities Net cash provided by (used in) investing activities Class of Warrant or Right [Axis] Net cash provided by (used in) financing activities Net increase (decrease) in cash and cash equivalents and restricted cash Cash and cash equivalents and restricted cash - beginning of period Cash and cash equivalents and restricted cash - end of period Cash and cash equivalents and restricted cash Organization and Nature of the Business [Abstract] Summary of Significant Accounting Policies [Abstract] Fair Value of Financial Instruments [Abstract] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Marketable Debt Securities [Abstract] Marketables Debt Securities [Abstract] Marketable debt securities: Financial Instrument [Axis] Asset Class [Axis] Debt Instrument [Axis] Schedule of Interest and Investment Income [Abstract] Total Interest and investment income (expense) Prepaid Expenses and Other Current Assets [Abstract] Total Prepaid expenses and other current assets Other Assets [Abstract] Total Other assets Accrued Expenses and Other Current Liabilities [Abstract] Total Accrued expenses and other current liabilities Leases [Abstract] Schedule of Lease Expense [Abstract] Total Schedule of Weighted Average Discount Rate and Weighted-Average Remaining Lease Term for Operating Leases [Abstract] Schedule of Annual Minimum Lease Payments of the Company’s Operating Lease Liabilities [Abstract] Total future operating lease payments Commitments and Contingencies [Abstract] Stockholders’ Equity [Abstract] Number of Warrants Outstanding Number of Warrants Outstanding Stock-Based Compensation [Abstract] Restricted Stock Units, Non-vested Balance Restricted Stock Units, Non-vested Balance Weighted Average Grant Date Fair Value, Non-vested Balance Weighted Average Grant Date Fair Value, Non-vested Balance Number of Options, Balance Number of Options, Balance Common stock subject to outstanding awards Weighted Average Exercise Price, Balance Weighted Average Exercise Price, Balance Aggregate Intrinsic Value, Balance Aggregate Intrinsic Value, Balance Derivative Instrument [Axis] Net Income (Loss) per Common Share [Abstract] Schedule of Net Income (Loss) Per Share Attributable to Common Stockholders, Basic and Diluted [Abstract] Antidilutive Securities [Axis] Segment Information [Abstract] Subsegments [Axis] Net income (loss) Segments [Axis] Jesse Shefferman [Member] June 16, 2026 – April 28, 2028 [Member] September 25,2026 – April 28, 2028 [Member] Jacqueline Zummo [Member] September 24, 2026 – June 30, 2028 [Member] Document Type Document Quarterly Report Document Period End Date Document Fiscal Year Focus Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Amendment Flag Document Fiscal Period Focus Current Fiscal Year End Date Assets Current assets: Cash and cash equivalents Marketable debt securities Estimated Fair Value Restricted cash, non-current Marketable debt securities, non-current Property and equipment, net Operating lease right-of-use asset Liabilities and Stockholders’ Equity Current liabilities: Accounts payable Operating lease liability Operating lease liability, non-current Commitments and contingencies (Note 9) Stockholders’ Equity: Series 1 Convertible Preferred Stock, 8,028 shares authorized at June 30, 2026 and December 31, 2025, 872 and 5,615 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized (in Shares) Preferred stock, shares authorized Preferred stock, shares issued (in Shares) Preferred stock, shares issued Preferred stock, shares outstanding (in Shares) Preferred stock, shares outstanding Common stock, 59,083,935 and 53,587,260 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common stock, par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares authorized Common stock, shares issued (in Shares) Common stock, shares issued Common stock, shares outstanding (in Shares) Common stock, shares outstanding Additional paid-in capital Accumulated deficit Accumulated other comprehensive income (loss) Operating expenses: Research and development General and administrative Other income (expense), net: Other income (expense) Other comprehensive income (loss): Net unrealized gain (loss) on marketable debt securities Net income (loss) per share attributable to common stockholders, basic (in Dollars per share) Net income (loss) per share attributable to common stockholders, basic Net income (loss) per share attributable to common stockholders, diluted (in Dollars per share) Net income (loss) per share attributable to common stockholders, diluted Weighted-average shares outstanding, basic (in Shares) Weighted-average shares of common stock outstanding, basic Weighted-average shares outstanding, diluted (in Shares) Weighted-average shares of common stock outstanding, diluted Issuance of common stock upon conversion of Series 1 Preferred Stock Issuance of common stock upon conversion of Series 1 Preferred Stock (in Shares) Issuance of common stock upon exercise of pre-funded warrants Issuance of common stock upon exercise of pre-funded warrants (in Shares) Issuance of common stock from December 2024 Public Offering, net of offering costs of $214 Issuance of common stock from December 2024 Public Offering, net of offering costs of $214 (in Shares) Public offering, net of offering costs Issuance of common stock upon settlement of restricted stock units (in Shares) Stock-based compensation - restricted stock units Stock-based compensation - stock options Unrealized gain (loss) on marketable debt securities Issuance of common stock upon exercise of stock options Issuance of common stock upon exercise of stock options (in Shares) Number of Options, Exercised Issuance of common stock upon exercise of common warrants Issuance of common stock upon exercise of common warrants (in Shares) Cash flows from operating activities: Adjustments to reconcile net income (loss) to net cash used in operating activities: Stock-based compensation Stock-based compensation costs Total stock-based compensation Stock-based compensation expense Operating lease right-of-use asset Depreciation Amortization of premium (Accretion of discount) on marketable debt securities Changes in operating assets and liabilities: Accounts payable Accrued expenses and other current liabilities Operating lease liabilities Cash flows from investing activities: Proceeds from maturity and redemption of marketable debt securities Cash flows from financing activities: Proceeds from exercise of Underwriters’ Option in December 2024 Public Offering, net of offering costs of $214 Public Offering, net of offering costs Proceeds from exercise of warrants Proceeds from exercise of stock options Supplemental disclosure of non-cash investing and financing activities: Proceeds from exercise of stock options included in other current assets and additional paid-in-capital Purchase of property and equipment included in accounts payable and property and equipment Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets: Cash and cash equivalents: Cash and cash equivalents Issuance of common stock upon settlement of restricted stock units Prepaid expenses and other current assets Other assets Purchase of marketable debt securities Purchase of property and equipment Offering costs paid in connection with public offerings